A survey of examining herd measles immunity in adults over 35 years old

Cover Page

Cite item

Abstract

A high measles incidence rate has been registered in Russia in recent years, with adults being actively involved in the epidemic process (about 40% of patients), thereby underlying relevance of assessing herd immunity in different  age groups to measure its risk. The data on examining serum antibodies to measles virus in 402 residents of Petrozavodsk are shown: 164 and 238 subjects were born in 1948–1968 (51–71 years) and 1970–1983 (36–50 years), respectively. It was found that the second group had significantly higher percentage not only of seropositive persons (94.1±1.5 vs. 77.4±3.3%, respectively), but also frequency of detected high IgG level (5 and more IU/l) reaching 39.7±3.5 vs. 15.4±5.8%, respectively. Analysis of vaccination history showed that of 351 people with protective antibody levels, 20.9% were vaccinated once or twice, 14 of them in childhood and 63 within the 15 years prior to the study. Of the 51 people with no measles antibodies or below protective level, 13.7% were vaccinated: five in childhood, and two within the last 15 years. Among those who was born in 1948–1968, 87.1±2.2% provided no information about previous vaccinations and probably were not vaccinated. In this group, percentage of those examined with a protective antibody level was significantly higher than in the 36–50 years group — 87.1±2.2 and 62.2±4.3%, respectively. In addition, 23 subjects confirmed that they recovered after measles in childhood. Of these, antibodies were detected in 21 subjects, including 9 having serum titer at level of 5 or more IU/ml. Until 1969, the Republic of Karelia registered a high level of measles morbidity (477–2176,0 per 100 thousand). The predominance in the group born before 1969, individuals seropositive to measles mainly at high titer, indicates that intense post-infectious immunity was preserved. The lack of protective level of antibodies to measles virus in 22.6% of persons aged 36–50 years (1969–1983 year of birth), due to the low level of post-infectious and insufficient durability of post-vaccination immunity allowing to definer them as a high risk group for measles infection.

About the authors

L. V. Rubis

Medical Institute of Petrozavodsk State University; City Polyclinic No. 4

Author for correspondence.
Email: rublusja@mail.ru
ORCID iD: 0000-0001-6602-9621

Lyudmila V. Rubis, PhD (Medicine), Associate Professor, Department of Faculty Therapy, Phthisiology, Infectious Diseases and Epidemiology, Medical Institute of Petrozavodsk State University; Epidemiologist of City Polyclinic No. 4

184034, Petrozavodsk, Noibrandenburgskaja str., 1, City Polyclinic No. 4
Phone: +7 921 469-20-78

Russian Federation

References

  1. Галазка А. Общая иммунология. Женева: ВОЗ, 1993. 29 с.
  2. Голубкова А.А., Платонова Т.А., Харитонов А.Н., Сергеев А.Г., Леленкова Е.В., Южанина Т.С. Эпидемический процесс коревой инфекции в период ее элиминации и стратегические направления контроля в условиях реального времени // Пермский медицинский журнал. 2017. Т. 34, № 4. С. 67–73.
  3. Инфекционная заболеваемость в Северо-Западном федеральном округе России. Совершенствование технологий эпидемиологического надзора и профилактики. Аналитический обзор. СПб.: СПбНИИЭМ им. Пастера, 2001. С. 17–18.
  4. Медуницын Н.В., Олефир Ю.В., Меркулов В.А., Бондарев В.П. Персональный и коллективный иммунитет при вакцинации // БИОпрепараты. Профилактика, диагностика, лечение. 2016. Т. 16, № 4. С. 195–207.
  5. МУ 3.1.2943-11. Организация и проведение серологического мониторинга состояния коллективного иммунитета к инфекциям, управляемым средствами специфической.
  6. О состоянии санитарно-эпидемиологического благополучия населения Российской Федерации в 2018 году. Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2019. С. 140–142.
  7. О состоянии санитарно-эпидемиологического благополучия населения Российской Федерации в 2017 году. Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2018. 135 с.
  8. Рыкушин Ю.П. Эпидемиологические обоснования ликвидации инфекционных болезней. Актовая речь. Л.: Изд. НИИЭМ им. Пастера, 1988. С. 17–21.
  9. Топтыгина А.П., Смердова М.А., Наумова М.А., Владимирова Н.П., Мамаева Т.А. Влияние особенностей популяционного иммунитета на структуру заболеваемости корью и краснухой // Инфекция и иммунитет. 2018. Т. 8, № 3. С. 341–348. doi: 10.15789/2220-7619-2018-3-341-348
  10. Червякова Е.М., Медведева Э.Я., Галкина А.А., Микаэлян С.М., Цой Е.Р., Высоцкая И.В. Анализ напряженности иммунитета к вирусу кори и определение коллективного иммунитета у персонала двух крупных стационаров г. Санкт-Петербурга // Проблемы медицинской микологии. 2019. Т. 21, № 2. С. 148.
  11. Элиминация кори и краснухи. Основы процесса верификации в Европейском регионе ВОЗ. Женева: ВОЗ, 2012. 30 c.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2020 Rubis L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies